Inventor · Bensheim, DE

Walter Mier

22Patents
5h-index
38Co-inventors
69Inventor score

Filing activity: Oct 28, 1998 → Jan 7, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US9078929B2 ε-Polylysine conjugates and the use thereof Chemistry; Metallurgy 15 Active
US6369109B1 Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumor Chemistry; Metallurgy 13 Expired
US10398791B2 Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer Chemistry; Metallurgy 10 Active
US10471160B2 Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer Chemistry; Metallurgy 9 Active
US11045564B2 Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer Chemistry; Metallurgy 6 Active
US6417339B1 Dendrimers based on saccharides Chemistry; Metallurgy 4 Expired
US10065993B2 Peptides and peptide/active compound conjugates for renal targeting Chemistry; Metallurgy 3 Active
US11951190B2 Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the treatment of prostate cancer Chemistry; Metallurgy 2 Active
US11931430B2 Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer Chemistry; Metallurgy 2 Active
US9562076B2 Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as HBV and HDV entry inhibitors Chemistry; Metallurgy 2 Active
US10253099B2 Conjugates of proteins and multivalent cell-penetrating peptides and their uses Chemistry; Metallurgy 1 Active
US6891033B2 Labelling compounds for the simple synthesis of 3'-[18F]fluoro-3'-deoxythymidine and a method for the production thereof Chemistry; Metallurgy 1 Expired
US9808535B2 Conjugates for protection from nephrotoxic active substances Chemistry; Metallurgy 1 Active
US9868768B2 Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as vehicles for the specific delivery of compounds to the liver Emerging Cross-Sectional Technologies 0 Active
US10513539B2 Hydrophobic modified peptides and their use for liver specific targeting Chemistry; Metallurgy 0 Active
US10363323B2 Hydrophobic modified peptides for liver specific diagnosis Emerging Cross-Sectional Technologies 0 Active
US11401304B2 Cyclic NTCP-targeting peptides and their uses as entry inhibitors Emerging Cross-Sectional Technologies 0 Active
US10653796B2 Liposomes containing cell penetrating peptides and tetraetherlipids for the oral delivery of macromolecules Human Necessities 0 Active
US10716757B2 Liposomal formulation for the oral hepatic delivery of drugs Human Necessities 0 Active
US10413614B2 Conjugates for protection from nephrotoxic active substances Chemistry; Metallurgy 0 Active
US11202833B2 Methylglyoxal-scavenging cyclic peptides and their use for the prevention and treatment of diseases associated with elevated methylglyoxal levels Human Necessities 0 Active
US10703796B2 CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.